| Scenario Name                | Date    | Euro area real GDP growth | Euro area inflation | Euro area bilateral dollar exchange rate (USD/euro) | Developing Asia real GDP growth | Developing Asia inflation | Developing Asia bilateral dollar exchange rate (F/USD, index) | Japan real GDP growth | Japan inflation | Japan bilateral dollar exchange rate (yen/USD) | U.K. real GDP growth | U.K. inflation | U.K. bilateral dollar exchange rate (USD/pound) |
|------------------------------|---------|---------------------------|---------------------|-----------------------------------------------------|---------------------------------|---------------------------|---------------------------------------------------------------|-----------------------|-----------------|------------------------------------------------|----------------------|----------------|-------------------------------------------------|
| Supervisory Severely Adverse | 2022 Q1 | -4.1                      | 3.7                 | 1.112                                               | -4.2                            | 1.5                       | 93.7                                                          | -6.7                  | -0.3            | 109.3                                          | -2.5                 | 4.0            | 1.327                                           |
| Supervisory Severely Adverse | 2022 Q2 | -3.5                      | 3.3                 | 1.093                                               | -1.5                            | 0.3                       | 95.3                                                          | -4.3                  | -0.4            | 107.9                                          | -2.8                 | 3.5            | 1.304                                           |
| Supervisory Severely Adverse | 2022 Q3 | -2.6                      | 2.4                 | 1.046                                               | -0.3                            | -0.5                      | 99.6                                                          | -2.5                  | -1.4            | 107.3                                          | -2.0                 | 2.8            | 1.248                                           |
| Supervisory Severely Adverse | 2022 Q4 | -2.3                      | 0.4                 | 1.010                                               | -0.1                            | -2.0                      | 103.1                                                         | -2.1                  | -2.3            | 106.5                                          | -1.8                 | 1.9            | 1.205                                           |
| Supervisory Severely Adverse | 2023 Q1 | -2.1                      | -0.2                | 1.002                                               | 0.7                             | -2.9                      | 104.0                                                         | -1.6                  | -2.7            | 105.4                                          | -1.6                 | 1.1            | 1.195                                           |
| Supervisory Severely Adverse | 2023 Q2 | -1.9                      | -0.5                | 0.993                                               | 1.3                             | -3.5                      | 104.9                                                         | -1.2                  | -2.9            | 105.1                                          | -1.4                 | 0.5            | 1.184                                           |
| Supervisory Severely Adverse | 2023 Q3 | 1.0                       | -0.7                | 0.997                                               | 2.8                             | -4.0                      | 104.5                                                         | 1.0                   | -2.8            | 105.4                                          | 1.0                  | 0.1            | 1.190                                           |
| Supervisory Severely Adverse | 2023 Q4 | 4.0                       | -0.5                | 1.002                                               | 5.9                             | -3.9                      | 104.0                                                         | 3.0                   | -2.4            | 105.6                                          | 4.0                  | 0.0            | 1.195                                           |
| Supervisory Severely Adverse | 2024 Q1 | 5.0                       | -0.2                | 1.019                                               | 8.0                             | -3.5                      | 102.2                                                         | 4.0                   | -1.8            | 106.5                                          | 5.0                  | 0.3            | 1.216                                           |
| Supervisory Severely Adverse | 2024 Q2 | 6.0                       | 0.2                 | 1.055                                               | 10.1                            | -2.6                      | 98.7                                                          | 5.0                   | -1.0            | 106.7                                          | 6.0                  | 0.8            | 1.259                                           |
| Supervisory Severely Adverse | 2024 Q3 | 7.0                       | 0.8                 | 1.074                                               | 11.8                            | -1.3                      | 97.0                                                          | 5.5                   | -0.1            | 107.3                                          | 7.0                  | 1.5            | 1.281                                           |
| Supervisory Severely Adverse | 2024 Q4 | 8.0                       | 1.4                 | 1.093                                               | 11.7                            | 0.1                       | 95.3                                                          | 6.0                   | 0.7             | 107.6                                          | 8.0                  | 2.1            | 1.304                                           |
| Supervisory Severely Adverse | 2025 Q1 | 9.0                       | 2.1                 | 1.112                                               | 12.7                            | 1.8                       | 93.7                                                          | 7.0                   | 1.4             | 108.2                                          | 9.0                  | 2.7            | 1.327                                           |